Suprême SAS (Gourmey) has become the first European company to obtain regulatory approval for a cultivated meat product, from the Singapore Food Agency. It has now set its sights on the Australian market, applying for its cell cultured duck to be used as a food ingredient under the Food Standards Australia and New Zealand (FSANZ) Code.
The news follows Sydney-based biotech company Vow’s landmark FSANZ approval for its cultured quail products in June, making Australia and New Zealand the fourth country globally to achieve this under specific circumstances, after Singapore, Israel, and the US.
Vow began getting its name out quickly, releasing collaborative menu items with restaurants around central Sydney, and recently launched online direct-to-consumer sales for delivery in the Greater Sydney region, selling home-ready cell-cultured quail products under its consumer brand, Forged.
Gourmey’s application to FSANZ makes it the first international company to enter the scientific risk assessment process in Australia. The summary stated the cell cultured duck will be mixed with other authorised ingredients to be used for duck meat analogues such as ‘cell cultured foie gras’ and ‘cell cultured duck pâté’, similar to what Vow is producing.
The specifics of the company’s product state the cell cultured duck is obtained from duck embryonic stem cells (dESC) isolated from fertilised duck eggs from the species Anas platyrhynchos domesticus (Pekin duck). The novel food contains a minimum of 10 per cent protein and is made using a cell line that has been fully characterised and has not been genetically modified.
According to FSANZ’s 2024 consumer insights report, although over half of consumers remain unconfident in the safety of cell-cultured/cultivated meat and dairy, overall confidence in cell-cultured/cultivated meat and dairy increased between 2023 and 2024.
Based in Paris, Gourmey recently acquired another French company, Vital Meat, to form Parima, aiming to be a new European champion for cultivated proteins and foods. The new company brings together Gourmey’s high-value duck and poultry cell lines and Vital Meat’s scalable cell-based chicken production, ready to tackle large-volume production, supply chain integration, and cost parity with high-value meats.
Parima combines Gourmey’s full-stack industrial platform, including premium cultivated duck with independently verified production costs below $13/kg (€7.00), with Vital Meat’s Nantes infrastructure, namely its 2000‑litre bioreactor capacity and advanced avian cell lines developed from over 25 years of research.
The company stated the combined platform is supported by 15+ patent families and 70+ patent applications. Its cultivated chicken landed approval from the Singapore Food Agency last week, now leading the cultured meat sector with eight active regulatory filings across Europe, Asia, and North America.
Parima’s near-term goal is to become the first cultivated food company positioned for regulatory approval of two species (duck and chicken), with applications spanning premium dining to large-scale B2B ingredients.
